IGRA (interferon gamma release assay)
PerkinElmer's Oxford Immunotec Gains FDA Go-Ahead for TB Test Automation
The PerkinElmer subsidiary said its T-Cell Select reagent kit reduces hands-on lab work and cost and simplifies blood sample storage.
Molecular TB Assay From PBD Biotech Shows Promise in Detecting Latent-to-Active Disease Risk
Premium
The blood-based assay, called Actiphage, combines phage-induced lysis of infectious bacteria and molecular detection of bacterial DNA.
Qiagen Next-Gen QuantiFeron Tuberculosis Test Gains Chinese Regulatory Approval
The new approval for QuantiFeron-TB Gold Plus adds to prior regulatory approvals in the US and other countries around the world, including CE-IVD marking.
Qiagen Obtains CE Mark for Assay Measuring T-Cell Response to SARS-CoV-2
Qiagen said its IGRA T-cell test can contribute insights into the immune response to a SARS-CoV-2 infection that go beyond what serology testing alone can provide.
Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test on Benchtop Platform
The approval broadens accessibility in the US to a highly automated workflow for latent TB testing using a blood-based assay and benchtop platform.
Jan 7, 2021
PerkinElmer to Buy Oxford Immunotec for $591M
May 5, 2020
Oxford Immunotec Q1 Revenues Fall 6 Percent
Nov 5, 2019
Oxford Immunotec Q3 Revenues Grow 32 Percent
Aug 6, 2019
Oxford Immunotec Q2 Revenues Jump 18 Percent
May 9, 2019
Oxford Immunotec Q1 Revenues Jump 27 Percent
Jan 31, 2019